Malignant Syndrome in a Patient with Parkinson's Disease
Malignant syndrome during the course of Parkinson’s disease usually occurs because of withdrawal or dose reduction of anti-Parkinsonian drugs, especially levodopa and may be fatal. Fever, rigidity, autonomic disfunction, elevated creatinin kinase level and confusion are the major clinical findings....
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2012-09-01
|
| Series: | Türk Nöroloji Dergisi |
| Subjects: | |
| Online Access: | http://www.tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-39358 |
| _version_ | 1797906294135324672 |
|---|---|
| author | Nesrin Helvacı Yılmaz Gökçen Duymaz Mehmet Akif Yaşar |
| author_facet | Nesrin Helvacı Yılmaz Gökçen Duymaz Mehmet Akif Yaşar |
| author_sort | Nesrin Helvacı Yılmaz |
| collection | DOAJ |
| description | Malignant syndrome during the course of Parkinson’s disease usually occurs because of withdrawal or dose reduction of anti-Parkinsonian drugs, especially levodopa and may be fatal. Fever, rigidity, autonomic disfunction, elevated creatinin kinase level and confusion are the major clinical findings. We aimed to present a patient that was treated in our intensive care unit in order to emphasise the importance of correct diagnosis of this disease, to discuss the precipitating factors and to highlight the importance of early treatment |
| first_indexed | 2024-04-10T10:18:36Z |
| format | Article |
| id | doaj.art-2b9003d1dbc64b34bde757c2853f1561 |
| institution | Directory Open Access Journal |
| issn | 1301-062X 1309-2545 |
| language | English |
| last_indexed | 2024-04-10T10:18:36Z |
| publishDate | 2012-09-01 |
| publisher | Galenos Yayinevi |
| record_format | Article |
| series | Türk Nöroloji Dergisi |
| spelling | doaj.art-2b9003d1dbc64b34bde757c2853f15612023-02-15T16:21:44ZengGalenos YayineviTürk Nöroloji Dergisi1301-062X1309-25452012-09-0118312312510.4274/Tnd.39358Malignant Syndrome in a Patient with Parkinson's DiseaseNesrin Helvacı Yılmaz0Gökçen Duymaz1Mehmet Akif Yaşar2Department Of Neurology, Universal Group Hospital Aksaray, İstanbul, TurkeyDepartment Of Anesthesiology And ReanimationDepartment Of Anesthesiology And ReanimationMalignant syndrome during the course of Parkinson’s disease usually occurs because of withdrawal or dose reduction of anti-Parkinsonian drugs, especially levodopa and may be fatal. Fever, rigidity, autonomic disfunction, elevated creatinin kinase level and confusion are the major clinical findings. We aimed to present a patient that was treated in our intensive care unit in order to emphasise the importance of correct diagnosis of this disease, to discuss the precipitating factors and to highlight the importance of early treatmenthttp://www.tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-39358Parkinson’s diseasemalignant syndromelevodopainfection |
| spellingShingle | Nesrin Helvacı Yılmaz Gökçen Duymaz Mehmet Akif Yaşar Malignant Syndrome in a Patient with Parkinson's Disease Türk Nöroloji Dergisi Parkinson’s disease malignant syndrome levodopa infection |
| title | Malignant Syndrome in a Patient with Parkinson's Disease |
| title_full | Malignant Syndrome in a Patient with Parkinson's Disease |
| title_fullStr | Malignant Syndrome in a Patient with Parkinson's Disease |
| title_full_unstemmed | Malignant Syndrome in a Patient with Parkinson's Disease |
| title_short | Malignant Syndrome in a Patient with Parkinson's Disease |
| title_sort | malignant syndrome in a patient with parkinson s disease |
| topic | Parkinson’s disease malignant syndrome levodopa infection |
| url | http://www.tjn.org.tr/jvi.aspx?pdir=tjn&plng=eng&un=TJN-39358 |
| work_keys_str_mv | AT nesrinhelvacıyılmaz malignantsyndromeinapatientwithparkinsonsdisease AT gokcenduymaz malignantsyndromeinapatientwithparkinsonsdisease AT mehmetakifyasar malignantsyndromeinapatientwithparkinsonsdisease |